Jeito Capital
Overview
Jeito Capital is a leading global independent private equity firm dedicated to the biopharma sector that finances and accelerates breakthrough medical innovation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Alentis Therapeutics | Nov 2024 | Series D | Lead |
| Odyssey Therapeutics | Sep 2025 | Series D | Co-investor |
| XyloCor Therapeutics | Jan 2025 | Series B | Lead |
| Quell Therapeutics | Nov 2021 | Series B | Lead |
| Adcendo | Apr 2026 | Series C | Lead |
For institutional investors. Book with your work email.
Key People
Rafaèle Tordjman
Founder CEO
Sabine Dandiguian
Managing Partner
Pascal Touchon
Operating Partner
Ksenija Pavletic
Partner Investor, CCO
Mehdi AINOUCHE
Partner
Daniel Wolle
Principal
Julien ELRIC
Senior Principal
Annette Clancy
Operational Investor
Claudio Costa-Neto
Chief Scientific Officer, Chief Scientific Officer (CSO) & Operational Investor at Jeito Capital, Operational Investor at Jeito Capital
Rachel Mears
Investor - Life Sciences
Julie Darbellay
Investor Relations Jeito
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Jeito Capital based?
Jeito Capital is headquartered in Paris, France.
When was Jeito Capital founded?
Jeito Capital was founded in 2020.
How many portfolio companies does Jeito Capital have?
Jeito Capital has 25 portfolio companies in Caplight's dataset.
What are some companies in Jeito Capital's portfolio?
Portfolio companies visible on Caplight include Alentis Therapeutics, Odyssey Therapeutics, XyloCor Therapeutics, Quell Therapeutics, Adcendo.
What was Jeito Capital's most recent investment shown here?
Jeito Capital's most recent investment in this portfolio sample was in Adcendo in 2026.
What sectors does Jeito Capital focus on?
Jeito Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does Jeito Capital focus on?
Jeito Capital typically invests at the MultiStage stage.
What is Jeito Capital's AUM?
Jeito Capital's assets under management are estimated between $500.0M and $1.0B.